First Study on Anti-Malaria Medicine’s Use for Coronavirus Proves Unsuccessful
As the world grapples with the coronavirus, medical experts around the world are working on a vaccine to help stem the pandemic.
Hydroxychloroquine is one of the few available drugs that experts were confident that would show better symptoms and recovery in clinical trials for patients with COVID-19.
ALSO READ
Anti-Malaria Pills Do Not Cure Coronavirus, Cause Serious Side Effects: Experts
Professor Sunit K Singh, molecular immunology & virology and head of the molecular biology unit at Banaras Hindu University’s Institute of Medical Sciences in Varanasi, India said,
The combination therapy of azithromycin and hydroxychloroquine was thought to be better over the monotherapy of hydroxychloroquine to control the mixed infection of virus and bacteria.
Currently, the drug also known as Plaquenil is used for lupus and rheumatoid arthritis. It differs from chloroquine phosphate, another medicine being used for malaria which is also being looked at to treat the COVID-19. Both drugs have ..